Find the Right Test.
Understand the Result.
Know the Next Step.
From routine laboratory investigations to advanced molecular and genomic testing, Reficio connects diagnostic needs with structured testing pathways, qualified providers, and clinician-led interpretation.
What can we help you with?
Select your health concern, existing report, or institutional requirement to instantly view structured diagnostic pathways.
Cancer & Genetics Diagnostic Pathways
Reficio coordinates targeted cancer risk assessment, multi-gene NGS panels (BRCA1/2, Lynch Syndrome), and comprehensive genomic profiling to assist clinicians in precision oncology decisions.
Key Diagnostic Capabilities
- Hereditary cancer germline screening (30-gene panels)
- Comprehensive Somatic Solid Tumour Profiling (TSO500 / 523 Genes)
- Liquid Biopsy / Plasma ctDNA testing for actionable alterations
- Targeted single-gene RT-PCR / Sanger assays (EGFR, BRAF, KRAS)
- Clinical exome sequencing for familial syndromes
How Reficio Organises Your Testing
A clear, clinician-centred workflow connecting clinical requirements with verified laboratory fulfilment.
Tell Us What You Need
Select your health concern, existing lab report, or required investigation from our structured directory.
Find the Appropriate Pathway
Explore relevant routine, specialised, molecular, or genomic investigations organised by clinical depth.
Complete the Test & Continue Care
Connect with an appropriate diagnostic service and take the report back to your clinician for interpretation.
From Routine Testing to Precision Diagnostics
Most diagnostic journeys should not begin with the most complex test. Reficio organises available investigations across structured levels of diagnostic depth so patients and clinicians can choose options appropriate to the clinical context.
Routine Laboratory Investigations
CBC, LFT, KFT, Lipid, HbA1c, Thyroid & Essential Biochemistry
Specialised Biomarkers & Assays
ANA (IIF), ENA-17, AMH, hs-CRP, Iron Kinetics, Cortisol & Serology
Molecular Diagnostics (RT-PCR)
Quantitative Viral Loads (HBV/HCV), EGFR, BRAF V600E & Pathogen PCR
Next-Generation Sequencing (NGS)
30-Gene Hereditary Cancer, Clinical Exome (6,000+ OMIM Genes), CMA
Precision Oncology & Liquid Biopsy
Comprehensive Genomic Profiling (TSO500 / 523 Genes), Plasma ctDNA
Explore the Diagnostic Ecosystem
Browse our 781 routine/specialised tests or examine advanced genomic profiling panels.
Already Have a Lab Report?
Translate confusing blood test numbers and biomarker flags into structured, evidence-backed clinical context. Understand what questions to ask your doctor.
Advanced Molecular & Genomic Diagnostics
Structured access to next-generation sequencing, hereditary predisposition screening, and comprehensive somatic tumour profiling.
30-Gene Hereditary Cancer Germline NGS Panel with High-Resolution CNV
Identifies pathogenic germline variants conferring lifetime cancer predisposition for Hereditary Breast and Ovarian Cancer (HBOC), Lynch Syndrome, and Li-Fraumeni Syndrome.
Clinical Exome Sequencing (Mendelian Phenome > 6,000 Disease Genes)
Definitive molecular diagnosis for complex neurodevelopmental delays, inborn errors of metabolism, rare syndromic presentations, and atypical pediatric disorders.
Somatic Solid Tumor 52-Gene Comprehensive Theranostic NGS Panel
Identifies actionable predictive biomarkers for FDA/EMA approved targeted therapies (Osimertinib, Sotorasib, Dabrafenib+Trametinib, Larotrectinib, Trastuzumab) and resistance mutations.
Cell-Free circulating Tumor DNA (ctDNA) Liquid Biopsy Multiplex Assay
Minimally invasive molecular profiling for monitoring minimal residual disease (MRD), evaluating therapeutic response, and detecting emergent secondary resistance mechanisms (e.g. EGFR T790M/C797S or ESR1 mutations) prior to radiographic progression.
Built for Clinicians & Healthcare Institutions
Whether you are an individual consultant or managing a multi-specialty hospital, Reficio bridges diagnostic capability gaps seamlessly.
Expand Your Diagnostic Reach
Navigate diagnostic options from routine chemistry to targeted NGS panels. Coordinate investigations for your patients while maintaining complete clinical control.
- Access to 781 routine and advanced biomarker investigations
- Structured clinical exome and oncology panels
- Reports return directly to treating clinician for patient management
Expand Capability Without Building In-House
Enable your institution to offer specialised molecular, endocrine, and genomic investigations through Reficio's diagnostic coordination infrastructure.
- Expand test menu without capital expenditure on specialized sequencers
- Retain patient care continuity within your hospital ecosystem
- Configurable institutional arrangement with dedicated coordination
Why Choose Reficio?
Our platform combines transparent investigation structures, advanced genomic capabilities, and evidence-backed clinical frameworks.
781 Diagnostic Investigations
Standardised directory across haematology, biochemistry, immunology, endocrinology, microbiology, and molecular pathology.
Next-Generation Sequencing (NGS)
Targeted multi-gene hereditary cancer panels, clinical exome sequencing, and comprehensive somatic tumour profiling.
7 Structured Biological Pillars
Multi-system clinical framework connecting metabolic, reproductive, inflammatory, immune, and cellular longevity health.
Evidence-Linked Navigation
Diagnostic pathways structured with references to WHO Essential Diagnostics, ICMR recommendations, and international specialty guidelines.
Understand the Science Behind Your Health
The authority layer behind our diagnostic pathways. Explore our 7 interconnected biological pillars and educational knowledge centre.
Metabolic & Glycaemic Balance
Reproductive & Endocrine Vitality
Immune & Inflammatory Resilience
Cardiovascular & Vascular Reserve
Cellular Ageing & Longevity
Micronutrient & Follicular Health
Genomic Stability & Precision Oncology
Ready to Start Your Diagnostic Journey?
Connect with Reficio for individual diagnostic pathways, clinical case coordination, or hospital institutional partnerships.
For Patients & Families
Find tests, understand existing lab reports, or request sample collection.
For Doctors & Clinics
Access specialised biomarkers, exome sequencing, and precision oncology panels for your cases.
For Hospitals & Labs
Expand testing capabilities, request institutional partnership, or list diagnostic capabilities.